ORIGINAL RESEARCH
Accepted on 07 Aug 2025
Development of a novel prognostic score for 1-year survival in immunotherapy-treated patients with unresectable HCC: The ALIVE-IO score
doi 10.3389/fimmu.2025.1648248
941
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: